Don’t miss the latest developments in business and finance.

Shivinder Singh

If the amount is deposited, then the markets regulator will not make further recovery, the Securities Appellate Tribunal (SAT) said in its order passed on July 8.

Updated On: 14 Jul 2022 | 2:02 AM IST

The Supreme Court on Wednesday dismissed the plea for interim bail of former Fortis Healthcare promoter Shivinder Mohan Singh who along with others is accused of misappropriating Rs 2,397 crore.

Updated On: 16 Mar 2022 | 11:37 PM IST

he high court listed the matter for further hearing on November 11

Updated On: 05 Oct 2020 | 11:09 PM IST

SC has sought a response from former Fortis Healthcare promoter Shivinder Singh on a plea filed by ED against the Delhi HC order granting him bail in the Religare Finvest money laundering case

Updated On: 01 Aug 2020 | 7:06 PM IST

The high court on July 23 granted bail to Singh, saying it does not perceive any grave threat to the interests of the society or the public at large with his release

Updated On: 01 Aug 2020 | 6:21 PM IST

Economic offenses having deep-rooted conspiracies and involving loss of public funds need to be viewed seriously, says court

Updated On: 18 Jun 2020 | 6:55 AM IST

Additional Sessions Judge Sandeep Yadav extended Singh's custody by the Enforcement Directorate after it sought his 7-day custodial interrogation

Updated On: 19 Dec 2019 | 4:06 PM IST

Additional Sessions Judge Sandeep Yadav sent Singh to ED remand after the agency sought his 14-day custodial interrogation.

Updated On: 13 Dec 2019 | 7:51 PM IST

Daiichi Sankyo has alleged the brothers created encumbrances on 1.2 million shares of Fortis in violation of court orders

Updated On: 15 Nov 2019 | 11:40 AM IST

The misappropriation came to light after an independent forensic audit was conducted by the new board

Updated On: 11 Oct 2019 | 1:01 PM IST

The court also asked Shivinder to come out by October 30 with a 'viable' plan of payment of his share out of the arbitral award of Rs 35 billion

Updated On: 12 Oct 2018 | 8:57 AM IST

This is in relation to ongoing enforcement proceedings to realise a Rs 2,562-cr Singapore arbitration award in favour of Japanese pharma major Daiichi Sankyo

Updated On: 29 Nov 2016 | 12:53 AM IST